RXRX vs CODI-P-B

Comparison between Recursion Pharmaceuticals Inc - Class A (RXRX, Company) and Compass Diversified Holdings (CODI-P-B, Company).

5-Year PerformanceCODI-P-B has outperformed RXRX, delivering a return of +4.6% compared to -35.3%

RXRX vs CODI-P-B - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RXRX(COMPANY)	CODI-P-B(COMPANY)
Market Cap	$1.69B	$1.69B
Max Drawdown	93.13%	53.91%
Sharpe Ratio	-0.47	1.11
5Y Beta	2.63	0.23
Industry	Biotechnology	Other
P/E Ratio	-3.17	-23.54
5Y Dividends CAGR	N/A	4.56%
5Y EPS CAGR	-10.45%	N/A
Debt to Equity	0.00%	464.24%
Free Cash Flow Yield	-20.81%	0.60%
P/S Ratio	25.34	N/A
P/B Ratio	1.55	N/A

Market Cap

RXRX

$1.69B

Winner

CODI-P-B

$1.69B

Max Drawdown

RXRX

93.13%

Winner

CODI-P-B

53.91%

Sharpe Ratio

RXRX

-0.47

Winner

CODI-P-B

1.11

5Y Beta

RXRX

2.63

Winner

CODI-P-B

0.23

Industry

RXRX

Biotechnology

CODI-P-B

Other

P/E Ratio

RXRX

-3.17

Winner

CODI-P-B

-23.54

5Y Dividends CAGR

RXRX

N/A

CODI-P-B

4.56%

5Y EPS CAGR

RXRX

-10.45%

CODI-P-B

N/A

Debt to Equity

Winner

RXRX

0.00%

CODI-P-B

464.24%

Free Cash Flow Yield

RXRX

-20.81%

Winner

CODI-P-B

0.60%

P/S Ratio

RXRX

25.34

CODI-P-B

N/A

P/B Ratio

RXRX

1.55

CODI-P-B

N/A

RXRX vs CODI-P-B - Historical Returns

Returns include dividend reinvestment.

Period	RXRX	CODI-P-B
1 month	-16.15%	+0.50%
3 months	-1.53%	+0.51%
6 months	-19.10%	+14.37%
1 year	-40.48%	+28.86%
5 years(CAGR)	-35.29%	+4.59%
10 years(CAGR)	N/A	+7.17%
Max(CAGR)	-34.84%	+7.17%

RXRX

-16.15%

Winner

CODI-P-B

+0.50%

RXRX

-1.53%

Winner

CODI-P-B

+0.51%

RXRX

-19.10%

Winner

CODI-P-B

+14.37%

RXRX

-40.48%

Winner

CODI-P-B

+28.86%

5Y(CAGR)

RXRX

-35.29%

Winner

CODI-P-B

+4.59%

10Y(CAGR)

RXRX

N/A

CODI-P-B

+7.17%

Max(CAGR)

RXRX

-34.84%

Winner

CODI-P-B

+7.17%

RXRX vs CODI-P-B - Annual Returns (2018 - 2026)

Returns include dividend reinvestment.

Year	RXRX	CODI-P-B
2026	-23.33%	+30.02%
2025	-43.27%	-19.19%
2024	-31.51%	+5.44%
2023	+30.60%	+12.08%
2022	-57.24%	-10.58%
2021	-45.27%	+18.18%
2020	N/A	+6.78%
2019	N/A	+44.67%
2018	N/A	-18.92%

RXRX vs CODI-P-B Drawdown Comparison

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for CODI-P-B was -45.93%, occurring on May 21, 2025. Recovery took 316 trading sessions.

The current RXRX drawdown is -92.21%. The current CODI-P-B drawdown is -1.02%.

Rank	RXRX	CODI-P-B
#1	-93.13% Jul 13, 2021 - Mar 30, 2026	-45.93% Jan 16, 2025 - Apr 22, 2026
#2	-38.10% Apr 29, 2021 - Jun 17, 2021	-44.32% Jan 31, 2020 - Nov 16, 2020
#3	-10.54% Apr 16, 2021 - Apr 21, 2021	-25.94% Mar 6, 2018 - Feb 13, 2019
#4	-10.45% Jun 21, 2021 - Jul 6, 2021	-13.09% Aug 2, 2022 - Jun 30, 2023
#5	-8.29% Apr 21, 2021 - Apr 29, 2021	-8.35% Jun 30, 2023 - Jan 26, 2024
#6	N/A	-7.82% Feb 15, 2019 - Jun 7, 2019
#7	N/A	-7.30% Dec 23, 2021 - Jul 29, 2022
#8	N/A	-5.88% Jul 30, 2024 - Jan 16, 2025
#9	N/A	-4.25% Mar 20, 2024 - Apr 30, 2024
#10	N/A	-3.94% Apr 30, 2024 - Jul 26, 2024
#11	N/A	-3.80% May 20, 2026 - Jun 25, 2026
#12	N/A	-3.79% Sep 29, 2021 - Nov 3, 2021
#13	N/A	-3.71% Nov 10, 2021 - Dec 2, 2021
#14	N/A	-3.66% Apr 23, 2026 - May 20, 2026
#15	N/A	-2.80% Feb 29, 2024 - Mar 20, 2024

Correlation

Correlation between RXRX and CODI-P-B is -0.33 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.33

-101